Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

SpaceXs quarterly results and outlook are driving attention, with traders focused on rapid AI-compute growth, a return to profitability and plans for heavy infrastructure spending. Bulls see the results as evidence of an expanding AI business, while skeptics question the valuation, cash demands and potential share-unlock pressure; preliminary Tesla merger discussions add another speculative theme.

Netflixs quarterly earnings beat was overshadowed by softer Q4 guidance, slowing revenue growth and a lower advertising outlook, prompting a sharp selloff. Traders are divided between viewing the drop as an overreaction to an otherwise profitable quarter and worrying that weaker growth, engagement and competition will keep pressuring the stock.

Super Micros preliminary fiscal Q1 update sharply raised its sales outlook and projected improved gross margins, citing stronger AI-platform demand. Bulls welcomed the upside surprise and speculated about short covering, while skeptics questioned whether the gains and improved margins would hold.

SpaceXs strong AI-related results and spending outlook, alongside Super Micros sharply higher preliminary sales outlook, have traders debating whether Nvidias AI infrastructure demand remains robust. Bulls see the updates as evidence of sustained GPU demand, while skeptics question the debt, power needs, and eventual returns behind the buildout.

SELLAS shares sharp rebound has traders focused on the anticipated 80th-event trigger and final analysis of its Phase 3 REGAL AML trial, with some also speculating about a buyout. The event count and trial results remain unconfirmed; bullish expectations of a major catalyst are countered by skepticism that the move is trading momentum without new data.

Bloom Energys upcoming Q3 earnings are the main focus, with traders debating whether results and guidance can justify its premium valuation after a sharp, volatile pullback. Bulls point to fuel-cell demand from AI data centers and recent power-project deals, while skeptics warn that expectations are high and the broader AI selloff could keep shares under pressure.

Traders are focused on potential DefenCath reimbursement upside after the HHS kidney-care plan highlighted barriers to financing dialysis innovation, which they see as support for CorMedixs request for a separate infection-prevention payment category. CMS action remains uncertain, and the discussion also weighs DefenCaths adoption and pricing against competition; REZZAYOs FDA priority review is another cited growth catalyst.

SOXX is drawing attention amid a prolonged semiconductor selloff, with traders questioning whether AI infrastructure spending and chip demand can justify the sectors high expectations amid financing concerns and competition. The community is split between expecting an oversold bounce on still-strong AI demand and warning that the decline could deepen.

Tesla and SpaceX have formed independent committees to explore a potential merger, fueling speculation that a combination could benefit Tesla while prompting skepticism about deal terms, valuation, and whether it will happen at all. Traders are also positioning around Teslas upcoming earnings, with debate over whether results or merger-related commentary will drive the next move.

Seas sharp selloff is being tied to plans for a Monee listing and a new Sea Cloud business, alongside concern about Shopees outlook and spending. Traders disagree on whether the moves could unlock value or add uncertainty, while many point to the stocks technical breakdown and others call it oversold.